Metahexamide: Difference between revisions
Rabin Bista (talk | contribs) Created page with "{{chembox new | Verifiedfields = changed | Watchedfields = changed | UNII_Ref = {{fdacite|correct|FDA}} | UNII = T3U6F5D722 | verifiedrevid = 444473742 |ImageFile=Metahexamide..." |
m Protected "Metahexamide": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)) |
(No difference)
| |
Latest revision as of 16:41, 20 August 2015
|
WikiDoc Resources for Metahexamide |
|
Articles |
|---|
|
Most recent articles on Metahexamide Most cited articles on Metahexamide |
|
Media |
|
Powerpoint slides on Metahexamide |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Metahexamide at Clinical Trials.gov Clinical Trials on Metahexamide at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Metahexamide
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Metahexamide Discussion groups on Metahexamide Patient Handouts on Metahexamide Directions to Hospitals Treating Metahexamide Risk calculators and risk factors for Metahexamide
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Metahexamide |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Metahexamide (INN) is an anti-diabetic drug from the group of sulfonylureas. It was first described in 1959.[1]
References
- ↑ Moss JM, Delawter D (September 1959). "Metahexamide in diabetes therapy". Ann NY Acad Sci. 82 (2): 614–7. doi:10.1111/j.1749-6632.1959.tb44940.x. PMID 14424617.